Empowered for durability, Kodiak’s high molecular weight ABCD Platform offers a unique approach to overcome the limitations of small molecule delivery to the eye 26 ABCD: Antibody Biopolymer Conjugate Drug ABCD Platform 950 kDa 1000 kDa

Unmet Needs in Retinal Disease Therapeutics - Page 26 Unmet Needs in Retinal Disease Therapeutics Page 25 Page 27